These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Pharmacologic features of proton pump inhibitors and their potential relevance to clinical practice. Welage LS Gastroenterol Clin North Am; 2003 Sep; 32(3 Suppl):S25-35. PubMed ID: 14556433 [TBL] [Abstract][Full Text] [Related]
63. [Effects of cimetidine, antacids and free diet on the pH of gastric content, in patients with peptic ulcer]. Ribeiro Tde C; Salgado JA; Castro Lde P AMB Rev Assoc Med Bras; 1981 Apr; 27(4):119-20. PubMed ID: 6974379 [No Abstract] [Full Text] [Related]
64. [Will anti-ulcer drugs soon differ only in their side effects?]. Miederer SE Fortschr Med; 1986 Dec; 104(3):918-20. PubMed ID: 2881864 [No Abstract] [Full Text] [Related]
65. Proton pump inhibitors and iron deficiency: is the connection real? Nand S; Tanvetyanon T South Med J; 2004 Sep; 97(9):799. PubMed ID: 15455957 [No Abstract] [Full Text] [Related]
66. Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man. Waldum HL; Fossmark R Gut; 2018 Jan; 67(1):199-200. PubMed ID: 29158236 [No Abstract] [Full Text] [Related]
67. [Mechanism of actions and clinical applications of proton pump inhibitors]. Seol SY Korean J Gastroenterol; 2006 Jul; 48(1):4-8. PubMed ID: 16861875 [TBL] [Abstract][Full Text] [Related]
68. Caution and patient safety concerns should guide us. Fraser GL; Riker RR Crit Care Med; 2005 Feb; 33(2):471-2; author reply 472. PubMed ID: 15699880 [No Abstract] [Full Text] [Related]
69. Proton-pump inhibitors and increased gastric cancer risk: time-related biases. Suissa S; Suissa A Gut; 2018 Dec; 67(12):2228-2229. PubMed ID: 29298870 [No Abstract] [Full Text] [Related]
70. Use of Proton Pump Inhibitors and risk of gastric cancer. Karakan T Turk J Gastroenterol; 2018 Jan; 29(1):143-144. PubMed ID: 29391326 [No Abstract] [Full Text] [Related]
71. Evaluation of proton pump inhibitors and risks of gastric cancer. Zeng R; Sha W; Wang J; Zhuo Z; Wu H; Leung FW; Chen H Gut; 2022 Sep; 71(9):1924-1926. PubMed ID: 34836917 [No Abstract] [Full Text] [Related]
76. Novel gastric mucosal findings in association with proton pump inhibitors. Isomoto H; Kurumi H Dig Endosc; 2017 May; 29(3):294-296. PubMed ID: 28199735 [No Abstract] [Full Text] [Related]
77. Physicochemical characterization of YJA20379-8, a new proton pump inhibitor. Kim J; Park C; Chang M; Cha J; Lee J; Chung Y Drug Dev Ind Pharm; 1999 Dec; 25(12):1283-7. PubMed ID: 10612025 [TBL] [Abstract][Full Text] [Related]
78. Proton pump inhibitors and the risk for gastric cancer: possible confounding by serum vitamin B Gueta I; Halkin H; Markovits N; Loebstein R Gut; 2018 Oct; 67(10):1904. PubMed ID: 29183922 [No Abstract] [Full Text] [Related]
80. The Effect of Chronic Use of Proton Pump Inhibitors on Gastric Cancer: Should We Be Aware of It? Liatsos C; Rokkas T Dig Dis; 2018; 36(6):395-396. PubMed ID: 29874647 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]